XML 14 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
License revenue $ 0 $ 3,600
Operating expenses:    
Research and development 15,410 21,059
General and administrative 11,429 12,780
Total operating expenses 26,839 33,839
Operating loss (26,839) (30,239)
Other income, net 2,052 1,200
Net loss before income taxes (24,787) (29,039)
Income tax provision 0 (17)
Net loss (24,787) (29,056)
Other comprehensive loss:    
Net unrealized (loss) gain on marketable securities (41) 739
Foreign currency translation adjustment (19) (7)
Comprehensive loss $ (24,847) $ (28,324)
Net loss per share — basic (in USD per share) $ (1.50) $ (2.90)
Net loss per share — diluted (in USD per share) $ (1.50) $ (2.90)
Weighted-average common shares used to compute net loss per share - basic (in shares) 16,479 10,030
Weighted-average common shares used to compute net loss per share - diluted (in shares) 16,479 10,030